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Abstract
The emergence of antibiotic-resistant pathogenic bacteria during the last decades has become a public health concern
worldwide. Aiming to explore new alternatives to treat antibiotic-resistant bacteria and given that the tellurium oxyanion
tellurite is highly toxic for most microorganisms, we evaluated the ability of sub lethal tellurite concentrations to strengthen
the effect of several antibiotics. Tellurite, at nM or mM concentrations, increased importantly the toxicity of defined
antibacterials. This was observed with both Gram negative and Gram positive bacteria, irrespective of the antibiotic or
tellurite tolerance of the particular microorganism. The tellurite-mediated antibiotic-potentiating effect occurs in laboratory
and clinical, uropathogenic Escherichia coli, especially with antibiotics disturbing the cell wall (ampicillin, cefotaxime) or
protein synthesis (tetracycline, chloramphenicol, gentamicin). In particular, the effect of tellurite on the activity of the
clinically-relevant, third-generation cephalosporin (cefotaxime), was evaluated. Cell viability assays showed that tellurite and
cefotaxime act synergistically against E. coli. In conclusion, using tellurite like an adjuvant could be of great help to cope
with several multi-resistant pathogens.
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Introduction
The constant emergence of clinically-relevant pathogens
exhibiting high levels of antibiotic resistance is nowadays a
worldwide health problem that poses new challenges to the
scientific community. Such scenario is even more worrying given
the ability of some pathogens to use antibiotics as the sole carbon
source [1].
During the last 50 years, the pharmaceutical industry has
introduced only one new antibiotic into the market. However and
even if new compounds with antibiotic ability are discovered, the
emergence of resistant strains is only a matter of time. This is the
main reason to look for new treatments, and in this context the use
of compounds strengthening the antibiotic effect is a choice that
worth to be evaluated [2]. Recently, it has been reported that some
antibiotics can act in a synergistic manner when used in
conjunction with genetically-modified bacteriophages or organo-
metallic compounds, among others [3,4,5].
In 2007, Kohanski et al. [6] showed that a common mechanism
underlying the toxicity of bactericidal antibiotics involves the
generation of the highly reactive oxygen species (ROS), hydroxyl
radical. Overall, this observation evidences that the general
mechanism(s) underlying antibiotic-toxicity are not fully under-
stood to date. On the other hand, in 1932 Fleming reported the
antibacterial properties of tellurite (TeO3
22) and penicillin [7] and
since then TeO3
22 has been used routinely to isolate tellurite-
resistant strains as Escherichia coli O157, Proteus spp., and other
bacteria [8].
During the last years our group has been interested in studying
the underlying molecular mechanism(s) of tellurite toxicity. It has
been shown that part of it results from ROS generation [9],
damage to metabolic enzymes [10,11], glutathione depletion [12]
or lipid peroxidation [13]. In this context, based on the high
toxicity exhibited by TeO3
22 against bacteria, its numerous cell
targets [14] and its apparent low noxiousness to eukaryotic cells
[15], we hypothesized that TeO3
22 could increase significantly the
antimicrobial effect of antibiotics.
In this work we report that sub lethal tellurite concentrations
increase the effect of ampicillin, tetracycline, chloramphenicol or
cefotaxime against E. coli and Pseudomonas aeruginosa. A similar, but
reduced effect was observed with the highly tellurite- and
antibiotic-resistant Staphylococcus aureus. Especially interesting was
the effect with cefotaxime, a widely-used, third-generation
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35452cephalosporin, which was found to act synergistically with tellurite
against E. coli.
Results
The ability of non-lethal tellurite concentrations to increase the
antibacterial effect was assessed by determining growth inhibition
zones. Antibiotics targeting different cellular processes were tested
in the absence or presence of sub lethal tellurite concentrations.
Bacterial species displaying distinct susceptibility to antibiotics
and TeO3
22 were evaluated to determine if the potentiating effect
was also observed with tellurite- or antibiotic-resistant bacteria.
Tellurite-mediated antibiotic-potentiating effects were observed
with AMP, CHL, TET, GEN and CTX when E. coli (highly
sensitive to tellurite, MIC 4 mM) was grown in tellurite-amended
LB plates. Approximately a 3-fold increase in growth inhibition
zones was observed with TET, CHL and CTX (Fig. 1A). In turn,
when P. aeruginosa was exposed to different antibiotics in the
presence of 4 mM TeO3
22 (MIC/80), a significant potentiating-
effect was observed only with CHL and GEN (Fig. 1B). Similar
results were obtained with S. aureus grown in 200 mM tellurite
(MIC/20)-containing plates (Fig. 1C).
Differences in growth inhibition areas observed among these
bacterial species are most probably due to their different
susceptibility to tellurite and antibiotics. P. aeruginosa exhibited
smaller inhibition zones than E. coli, which may reflect antibiotic
resistance genes that are absent in E. coli K12-derived laboratory
strains [16]. In our hands and depending on the particular
antibiotic, MIC values for these antibacterials decreased 25–75%
in the presence of sublethal tellurite concentrations.
Particularly interesting was the effect in E. coli exposed to CTX,
where the most significant inhibition zone increase was observed
in the presence of tellurite (Fig. 1A). CTX, a third-generation
cephalosporin, is routinely used to treat infections caused by
Gram-negative and Gram-positive pathogens and also as prophy-
lactic strategy [17]. Given the effect observed in sensitivity to CTX
and its clinical relevance, the tellurite-dependent potentiation on
CTX effect was further explored.
The minimal concentration of tellurite displaying CTX
potentiation was determined. A dose-dependent effect was
observed when tellurite concentrations ranging from 1/10 up to
1/1,000 of E. coli MIC were evaluated (Fig. 2). Although the
maximal effect was observed at 400 nM, half of this concentration
was used since the potentiating effect was still significant and
because this concentration seems not to affect eukaryotic cells
[15,18,19].
The cefotaxime MIC for E. coli was diminished 4 fold (0.13 to
0.03 mg/ml) when grown in the presence of tellurite. Surprisingly,
the CTX MIC for the antibiotic-resistant bacteria P. aeruginosa
decreased .30 fold (300 to 9.3 mg/ml) in the presence of 4 mM
tellurite. Since the CTX MIC is the same for pathogenic [20] and
laboratory E. coli strains, these results could be important in terms
of future applications of tellurite-mediated cefotaxime potentia-
tion. In this context and aiming to assess if the tellurite-
potentiating antibiotic effect was also observed with pathogenic
bacteria, clinical isolates were exposed to both antibacterials.
Growth inhibition zones resulting from antibiotic exposure in the
presence or absence of 200 or 400 nM tellurite were determined
for 20 clinical coliform isolates from patients suffering urinary
infection. A dose-dependent, tellurite-potentiating effect was
observed with all tested antibiotics. Interestingly, the most robust
effect was again observed with CTX, which was over 2 fold than
that observed with other antibiotics as STR, AMK, KAN and
TOB (Table 1).
To characterize the type of antimicrobial effect after exposing
bacteria simultaneously to tellurite and CTX, cell viability
determinations were carried out using different antibiotic concen-
trations in the presence of the tellurium oxyanion (Fig. 3). Growth
and cell viability were not severely affected when E. coli was
exposed to 200 nM tellurite. In fact, normal growth and viability
was restored after 3 h exposure (Fig. 3, squares).
While growth was not affected when cells were exposed
concurrently to 0.065 mg/ml CTX (MIC 0.13 mg/ml) and tellurite
(200 nM), the number of viable cells was strongly decreased as
determined by CFU counting (Fig. 3A). A similar result was
obtained upon exposing to the antibiotic alone, suggesting that the
effect observed with both CTX+tellurite depends mainly on
antibiotic-mediated damage.
When cells were grown in the presence of 0.13 mg/ml
cefotaxime, growth and viability recovered only after 7 h
treatment. The observed potentiating-effect at 3 or 7 h exposure
cannot be explained as the sum of tellurite- and CTX-independent
Figure 1. Tellurite-mediated antibiotic-potentiating effect in
different bacteria. Antibiotic-mediated inhibition growth zones were
determined for E. coli (A), P. aeruginosa (B) and S. aureus (C) grown in
the absence (white bars) or presence of the indicated tellurite (T)
concentrations as described in Methods. Values represent the average
of at least 4 independent trials and significance was determined using t-
test analysis (p,0.05). Significance values are (*) p,0.05, (**) p,0.01
and (***) p,0.001.
doi:10.1371/journal.pone.0035452.g001
Enhancing Antibiotic Effects by Tellurite
PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e35452effects (Fig. 3B). This indicates a tellurite/cefotaxime-mediated
synergistic effect in E. coli.
Finally, when the potentiating effect was assessed in cells
exposed to lethal CTX concentrations (0.5 mg/ml), the synergy
was represented by a difference of ,5 Dlog10 units after 20 h and
growth or cell viability was not recovered at all (Fig. 3C).
Discussion
Bacterial multi-resistance to different antibiotics has become a
severe problem worldwide. To face this situation, the scientific
community and pharmaceutical industry have made important
efforts to discover new compounds exhibiting antibacterial
properties. However, in the last 40 years these efforts have
resulted in the discovery of only 2 new antibiotics, the
oxazolidinone linezolid and the lipopeptide daptomycin [21,22].
The conventional treatment of bacterial infections currently lies
in administering antibiotics alone or in combination [23], or using
last-generation antibiotics as the case of the multi-resistant
Enterobacteriaceae with carbapenems [24]. In spite of this, strains
resistant to these new antibacterials emerge continuously, making
the situation critical.
Horizontal gene transfer is the principal mode of acquiring new
information by bacteria thus allowing them to cope with new
antibacterial agents. In this context, the idea of using 2 different
antibiotics to treat bacterial infections seems reasonable but there
is still a risk of acquiring resistance determinants. To avoid multi-
resistance emergence, the use of compounds exhibiting multi-
target toxicity is an interesting and novel alternative, since getting
a mutation or acquiring genetic determinants against these new
compounds is minimal. In this context, using molecules as tellurite
to potentiate the antibacterial effect seems to be a fine approach.
Although information regarding TeO3
22 toxicity for eukaryotic
cells is scarce to date, it has been shown that 50 mM tellurite
(.125-fold the maximal dose used in this work) seems not to affect
the viability of eukaryotic cells [15]. In fact, in different cell lines
death occurs at ,160–1,600 mM tellurite, as compared to the E.
coli 4 mM killing-dose. Despite the important effect in survival
observed in neurons [19] and erythrocytes exposed to 100–
500 mM tellurite [25], no significant effects have been reported
when lower concentrations were used [26]. Indeed, a therapeutic
use of tellurite as a red cell antisickling agent has been proposed
[24]. Although rats receiving 8 mM tellurite daily doses did not
reveal toxic effects over a year, tellurite-treated animals showed
increased mortality after 19 months [27,28]. Despite these
considerations, it results obvious that the real effect of tellurite
on eukaryotic cells has not been well established to date.
Considering the use of tellurite as strategy to kill bacteria
without affecting eukaryotic host cells, it was determined that sub
lethal TeO3
22concentrations increase the susceptibility of different
bacterial species to various antibiotics in either LB or Mu ¨eller-
Hinton media (not shown). The fact that increased growth
inhibition zones were observed with most tested antibiotics in
the presence of TeO3
22 (Fig. 1) suggests that this condition may
not be related to the antibiotic’s specific target. This allows
hypothesizing a common mechanism underlying the observed
potentiating effect. As shown by Kohanski et al. for bactericidal
antibiotics [6] and by our group for tellurite [9], these compounds
promote oxidative stress which could in part explain their toxicity.
Experiments to address this issue are under way in our laboratory.
Tellurite-mediated potentiation of TET, GEN and CHL is
probably consequence of a combined effect upon protein synthesis
(mediated by the antibiotic) and tellurite-induced protein oxida-
tion. In this context, E. coli protein misfolding/mistranslation or
oxidation has been observed upon exposure to some aminoglyco-
sides [29] or tellurite [9], respectively.
Major changes in growth inhibition zones observed with Gram
negative bacteria facing simultaneously tellurite and antibiotics are
probably consequence of their high tellurite susceptibility as
compared to that exhibited by Gram positive microorganisms
[14]. Differences in growth inhibition areas between E. coli and P.
aeruginosa may be explained because of the high antibiotic-
resistance levels exhibited by the last bacterium. In spite of this,
its susceptibility to antibiotics can be increased in the presence of
low tellurite concentrations (Fig. 1B). On the other hand, a less
robust effect was observed when S. aureus was exposed to tellurite
and antibiotics, probably because the high resistance to both
toxicants exhibited by this Gram positive rod.
A synergistic effect, evidenced by a difference of .2 log units in
cell viability, was observed when characterizing the magnitude and
the type of tellurite-mediated CTX-potentiating effect (Figs. 3B
and C). This was also the case with growth curves, where an
important decrease in OD600 was observed when exposing to both
antimicrobials (Fig. 3). Although viability was rather unaltered,
increased turbidity was observed when E. coli was exposed to
Figure 2. Minimal tellurite concentration causing a cefotaxime-
potentiating effect in E. coli. Inhibition growth zones were
determined as described in Methods using LB plates amended with
the indicated sub lethal tellurite concentrations (nM).
doi:10.1371/journal.pone.0035452.g002
Table 1. Tellurite-mediated antibiotic-potentiating effect in
clinical isolates.
Antibacterial Tellurite (nM)
0 200 400
Ctx 2.29 3.55 (55) 4.60 (100)
Cefl 1.31 1.87 (43) 2.39 (83)
Amp 1.50 2.07 (38) 2.31 (54)
Neo 1.45 2.11 (45) 2.63 (81)
Str 2.32 2.90 (24) 3.52 (51)
Gen 2.11 2.78 (32) 3.17 (51)
Amk 2.18 2.68 (22) 3.16 (45)
Kan 2.09 2.58 (23) 3.45 (65)
Tob 4.49 4.90 (9) 5.91 (31)
Antibiotic susceptibility, in the absence or presence of the indicated tellurite
concentrations, was assessed by growth inhibition zones (cm
2) as described in
Methods. Parentheses indicate per cent of susceptibility increase regarding the
respective control.
doi:10.1371/journal.pone.0035452.t001
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filamentation upon exposition to b-lactam agents as cefotaxime
[30]. Cell viability was recovered only 7 h after exposing to a lethal
cefotaxime concentration (0.5 mg/ml) (Fig. 3C), a result that may
reflect a decreased antibiotic bioavailability because of covalent
linkage formation with bacterial penicillin binding proteins (PBPs),
as has been described for other b-lactam antibiotics [31].
Since hydroxyl radical and superoxide formation occurs during
E. coli exposure to tellurite or bactericidal antibiotics, respectively
[6,9], the observed tellurite/cefotaxime synergistic effect would be
most probably due to an oxidative stress outbreak. This idea is
reinforced even with sub lethal antibiotic concentrations, where
enhanced DNA damage and mutation rate are observed [32].
Experiments to address this issue are currently being carried out in
our laboratory.
The idea of using TeO3
22 lies on its extremely high toxicity to
bacteria as compared to other metals or non metals as chromium,
lead, or manganese [14]. In addition to establishing an oxidative
stress status (9), the existence of multiple tellurite cell targets (13,
Figure 3. Cefotaxime and potassium tellurite acts synergistically in E. coli. Growth curves (left panels) and cell viability (right panels) were
determined at the indicated time intervals for E. coli exposed to 0.065 (A, sublethal), 0.13 (B, MIC) and 0.5 mg/ml (C, lethal) CTX in the absence or
presence of 200 nM tellurite. Controls contained no tellurite or cefotaxime. Data represent the mean of at least 3 independent trials. Refer to inset in
panel A for symbol meaning.
doi:10.1371/journal.pone.0035452.g003
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potentiating strategy is almost negligible.
Our findings strongly suggest that the use of tellurite (or similar
antimicrobials) as an antibiotic-potentiating adjuvant is a novel
and feasible strategy to face the antibacterial multi-resistance
problem. It is also particularly promising given that the
antibacterial-potentiating effect was observed with antibiotic-
resistant clinical isolates.
Finally, unveiling the molecular mechanism of the antibiotic-
potentiating effect described in this work should contribute to the
development of new molecules or compounds to be applied in new
therapies to treat infections caused by antibiotic-resistant bacteria.
Materials and Methods
Bacterial strains and culture conditions
E. coli BW25113, P. aeruginosa PAO1 and S. aureus were routinely
grown in Luria Bertani broth at 37uC with shaking. Minimal
inhibitory concentrations (MIC) were determined by serial
dilutions as described [11]. Growth inhibition zones were
determined as reported previously [9]. Briefly, cells were spread
on LB plates amended with TeO3
22 (0.2, 4 and 200 mM for E. coli,
P. aeruginosa and S. aureus, respectively). Sterile filter paper disks
(6 mm) containing ampicillin (100 mg, AMP), tetracycline (30 mg,
TET), cefotaxime (60 mg, CTX), chloramphenicol (25 mg, CHL)
or gentamicin (10 mg, GEN) were placed on the plate centres and
incubated overnight at 37uC.
Antibiotic susceptibility of clinical isolates
Twenty uropathogenic E. coli were isolated from patients
displaying urinary infection and purified by streaking on
MacConkey and LB agar plates. Identification was carried out
by conventional microbiological procedures. Cells were grown
overnight in LB media (OD600,0.6) and 50 ml were plated on
Mu ¨eller Hinton plates that contained or not 200 or 400 nM
tellurite. Sensidisks containing cefotaxime (CTX, 30 mg), cefalotin
(CEFL, 30 mg), ampicillin (AMP, 10 mg), neomycin (NEO, 30 mg),
streptomycin (STR, 10 mg), gentamycin (GEN, 10 mg), amikacin
(AMK, 30 mg), kanamycin (KAN, 30 mg) or tobramycin (TOB,
10 mg) were used in disk diffusion assays as described above.
Growth inhibition zones were determined for each antibiotic in
the absence or presence of 200 or 400 nM tellurite for all 20
isolates and averaged. Results were expressed as the mean of 3
independent trials.
Ethics statement
An individual, informed, written consent was obtained from
each participant allowing the samples to be used in this study.
Procedures for handling clinical samples were carried out in as
recommended in Biosafety Laboratory Manual (3
rd Ed., WHO,
2005). Microbiological procedures as well as carrying out this
study were specifically approved by the Ethics Committee of
Facultad de Ciencias, Universidad San Luis Gonzaga, Ica, Peru ´.
Viability assays
E. coli grown to OD600,0.3 was exposed to tellurite (0.05 mg/
ml) alone or in combination with CTX (0.065, 0.13 or 0.5 mg/ml).
At different time intervals samples were serially diluted (1:10) in
PBS buffer, pH 7.0. Ten ml of each dilution were seeded on LB
plates to determine the number of colony-forming units (CFU).
The CFU/ml was determined using the formula:
[(#colonies)*(dilution factor)]/(volume plated in ml) as previously
described [6].
Growth curves
E. coli grown to OD600,0.4 was incubated in the presence of
CTX or tellurite (see above for concentrations) at 37uC with
shaking and absorbance was recorded at 600 nm.
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